Materias dentro de su búsqueda.
Mostrando 593,701 - 593,720 Resultados de 594,273 Para Buscar '"Novelé"', tiempo de consulta: 3.36s Limitar resultados
  1. 593701
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Persistance à six mois des réponses immunitaires induites par une vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2 – cohorte ANRS0001S COV-POPART
  2. 593702
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Soins Intensifs (SI) en Infectiologie : Retex Covid et perspectives
  3. 593703
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evolution des comportements et des contacts sociaux impliqués dans la transmission infectieuse hors confinement durant la pandémie de COVID-19 en France
  4. 593704
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    G-VOC : Étude de la gravité du variant gamma du SARS-CoV-2 comparé aux variants antérieurs (virus historique, alpha et zêta).
  5. 593705
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ANRS0001S COV-POPART : Réponse humorale des personnes vivant avec le VIH à 12 mois d'un schéma de vaccination Covid-19
  6. 593706
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Utilisation de Nirmatrelvir/ritonavir chez des patients insuffisants rénaux chroniques sévères infectés par SARS-CoV-2
  7. 593707
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Intérêt du screening des marqueurs fongiques en unité conventionnelle chez les patients présentant une infection à SARS-CoV-2
  8. 593708
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study
  9. 593709
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Infections sévères à entérovirus chez les patients traités par rituximab pour une maladie auto-immune : série de cas et revue de la littérature
  10. 593710
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands
  11. 593711
    “…The “Endo-Circuit” is a novel, low-cost vascular model developed by Dr Tomoyuki Endo from Sendai, Japan to practice ECMO cannulation.8,9 [Figure: see text] Alternatively, a lower-fidelity model can be utilized if the Endo-Circuit is not available. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Extracorporeal Membrane Oxygenation (ECMO) for Refractory Cardiac Arrest
  12. 593712
    “…Ninety-seven percent of participants felt the trainers were realistic and 100% would recommend them for future simulation use. DISCUSSION: Novel 3D printed needle cricothyrotomy trainers are a much-needed addition to emergency medicine procedural training. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Innovations in Airway Education: 3D Printed Neonatal and Pediatric Needle Cricothyrotomy Trainers
  13. 593713
    “…BACKGROUND: Non-traumatic subarachnoid hemorrhage (SAH), primarily due to the rupture of intracranial aneurysms, contributes significantly to the global stroke population. A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)
  14. 593714
    “…Historically, less stringent criteria (clinical or microbiological [not combined], allowing symptom improvement/resolution) and various endpoints were used; success rates of 70–92% have been reported for NTF (Table 1). Gepotidacin, a novel, first-in-class, triazaacenaphthylene, bactericidal ABX has been investigated for uUTI treatment in 2 RCTs, EAGLE-2 (E-2; NCT04020341) and -3 (E-3; NCT04187144) following FDA/EMA guidance. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2837. Impact of Regulatory Guidelines on Therapeutic, Clinical, and Microbiological Success Rates in Uncomplicated Urinary Tract Infection: Results from a Two Phase 3 Randomized Controlled Trials of Oral Gepotidacin (EAGLE-2 and EAGLE-3)
  15. 593715
    “…AIMS: PTEN is a novel tumour suppressor which exhibits tyrosine phosphatase activity as well as homology to the cytoskeletal proteins tensin and auxilin. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
  16. 593716
    “…Therefore, the development of novel therapeutic strategies that are aimed at inducing apoptosis in rheumatoid synovial tissue is an attractive goal. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Apoptosis and p53 expression in rat adjuvant arthritis
  17. 593717
    por Kones, Richard
    Publicado 2011
    “…A combination of approaches, such as the addition of lifetime risk, refinement of risk prediction, guideline compliance, novel treatments, improvement in adherence, and primordial prevention, including environmental and social intervention, will be necessary to lower the present high risk burden.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
  18. 593718
    por Nasri, Hamid
    Publicado 2014
    “…While agents restoring the initial function of renal erythropoietin-producing cells could delay kidney fibrosis, further laboratory studies are necessary to clarify the cellular target of erythropoietin in the kidney and for developing a novel erythropoietin derivative or mimetic for kidney protection.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
  19. 593719
    “…BACKGROUND: Plants have been a major source of inspiration in developing novel drug compounds in the treatment of various diseases that afflict human beings worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chalepin: A Compound from Ruta angustifolia L. Pers Exhibits Cell Cycle Arrest at S phase, Suppresses Nuclear Factor-Kappa B (NF-κB) Pathway, Signal Transducer and Activation of Transcription 3 (STAT3) Phosphorylation and Extrinsic Apoptotic Pathway in Non-small Cell Lung Cancer Carcinoma (A549)
  20. 593720
    “…BACKGROUND: Nexvax2® is a novel, peptide-based, epitope-specific immunotherapy intended to be administered by regular injections at dose levels that increase the threshold for clinical reactivity to natural exposure to gluten and ultimately restore tolerance to gluten in patients with celiac disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Herramientas de búsqueda: RSS